Back
Hospital Admission Less than 30 Days after Chemotherapy: Results from a Chemotherapy-Specific Morbidity and Mortality Conference in Gynecologic Oncology
Lauren Philp, Tracilyn Hall, Lisa Diver, Annekathryn Goodman
J. Cancer Ther. Vol.11 No.6, June 28, 2020  DOI: 10.4236/jct.2020.116033
       (PDF  542K)     HTML      XML
Evaluation of a public expense-covered gynecologic screening program in Japan 2005-2009
Hiroshi Takagi, Satoshi Ichigo, Kazutoshi Matsunami, Atsushi Imai
Open J. Obstet. Gynecol. Vol.1 No.2, June 30, 2011  DOI: 10.4236/ojog.2011.12005
       (PDF  47K)     HTML     
The Prognostic Importance of EGFR and COX-2 Expression in Cervix Cancer Stages IIb-IVa
Parvin Adimi, Karina Dahl Steffensen, Doris Schledermann, Eva Rye Rasmussen, Anders Jakobsen
J. Cancer Ther. Vol.2 No.1, March 08, 2011  DOI: 10.4236/jct.2011.21002
       (PDF  13987K)     HTML     
Modified Triple P Approach by Gynecologic Oncologist-Led Team for Placenta Accreta Spectrum Improves the Outcome: Non-Randomized Controlled Trial
Mohammad Am Ahmed, Mostafa M. Khodry
Open J. Obstet. Gynecol. Vol.9 No.7, July 25, 2019  DOI: 10.4236/ojog.2019.97101
       (PDF  415K)     HTML      XML
Postoperative Nausea and Vomiting Prophylaxis with Ondansetron in Diagnostic Gynecologic Laparoscopy: Preemptive versus Preventive Method
Simin Atashkhoei, Eissa Bilehjani, Solmaz Fakhari, Faraji-Azad Hanieh
Adv. Reprod. Sci. Vol.5 No.1, January 13, 2017  DOI: 10.4236/arsci.2017.51001
       (PDF  389K)     HTML      XML
 
 
Top